Marker Therapeutics, Inc.
MRKR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14,958 | $21,354 | $13,660 | $28,304 |
| - Cash | $17,590 | $10,462 | $13,693 | $19,192 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2,632 | $10,892 | -$33 | $9,112 |
| Revenue | $1,233 | $861 | $349 | $2,252 |
| % Growth | 43.2% | 146.7% | -84.5% | – |
| Gross Profit | $1,233 | -$3,316 | -$2,786 | -$2,834 |
| % Margin | 100% | -385% | -798.1% | -125.9% |
| EBITDA | -$1,999 | -$4,261 | $0 | -$3,861 |
| % Margin | -162.1% | -494.8% | 0% | -171.5% |
| Net Income | -$1,999 | -$4,016 | -$4,446 | -$3,838 |
| % Margin | -162.1% | -466.3% | -1,273.6% | -170.4% |
| EPS Diluted | -0.12 | -0.29 | -0.4 | -0.42 |
| % Growth | 58.6% | 27.5% | 4.8% | – |
| Operating Cash Flow | -$2,736 | -$1,878 | -$5,500 | -$4,703 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$2,736 | -$1,878 | -$5,500 | -$4,703 |